The link to the conference is http://mds.kenes.com Myelodysplastic Syndrome is a disease of bone marrow failure, where blood cells fail to form because bone marrow stem cells fail to differentiate. The Company has filed one IND in this space on HemaXellerate treatment for aplastic anemia and is working on preclinical development of DiffronC, an siRNA based therapeutic targeting cancer stem cell genes involved in blood cell differentiation.
http://ift.tt/1yawH2d
http://ift.tt/1yawH2d
No comments:
Post a Comment